MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$42,526
Net Income
-$724,643
Net Profit Margin
-1704.00%
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2024-09-30
2024-06-30
Net sales
42,526
237,645
Cost of sales
11,881
64,390
Us-gaap_grossprofit
30,645
173,255
Selling, general and administrative expenses
411,683
425,100
Us-gaap_operatingincomeloss
-381,038
-251,845
Interest expense
-
58,301
Derivative, gain (loss) on derivative, net
-
121,319
The amount of change in fair value of derivative liabilities
-
-337,439
Amount of income expenses related to other non operating activities
-
82,624
Us-gaap_interestexpensenonoperating
54,914
-
Us-gaap_othernonoperatingincomeexpense
3,521
483,081
Us-gaap_gainlossonderivativeinstrumentsnetpretax
46,486
-
Change in fair value of derivative liabilities
-338,698
-
Us-gaap_nonoperatingincomeexpense
-343,605
-
Net loss
-724,643
231,236
Us-gaap_netincomelossavailabletocommonstockholdersbasic
-724,643
231,236
Basic EPS
0
0
Diluted EPS
-
0
Basic Average Shares
681,000,979
566,665,842
Diluted Average Shares
-
1,943,580,744
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Us-gaap_netincomelossavailabletocommonstockholdersbasic
-$724,643
Net loss
-$724,643
Net sales
$42,526
Us-gaap_operatingincomeloss
-$381,038
Us-gaap_nonoperatingincomeexpense
-$343,605
Us-gaap_grossprofit
$30,645
Us-gaap_gainlossonderivativeinstrumentsnetpretax
$46,486
Us-gaap_othernonoperatingincomeexpense
$3,521
Cost of sales
$11,881
Selling, general and
administrative expenses
$411,683
Change in fair value of
derivative liabilities
-$338,698
Us-gaap_interestexpensenonoperating
$54,914
Buy us a coffee
Electromedical Technologies, Inc (EMED)
Electromedical Technologies, Inc (EMED)